Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination intervention used in clinical trials, consisting of a placebo, calcium supplementation, and vitamin D supplementation. It is not a marketed pharmaceutical product but rather refers to the arms or groups in randomized controlled trials where participants may receive either placebo, calcium, vitamin D, or their combinations for comparative purposes. Calcium and vitamin D are essential nutrients involved in bone metabolism; calcium supports bone structure while vitamin D enhances intestinal absorption of calcium and has roles in musculoskeletal and immune function. Placebo serves as an inactive control to assess the efficacy of active interventions. This combination is primarily studied for its effects on bone health (fracture prevention), mortality, cardiovascular disease risk, cancer incidence/mortality, and other outcomes in older adults[2][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on placebo + calcium + vitamin d.